Logo Waystar Holding Corp

Waystar Holding Corp (WAY) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Waystar Holding Corp · Health Care · ref. ETF XLV · 51 calls · price $25.25
🔔Price alertsCreate an alert →
What the company does: Waystar Holding Corp. develops a cloud-based software solution for healthcare payments.

📈 Waystar Holding Corp (WAY) stock price

$25.25-34.0% over range
Aug 28, 25low $17.31 · high $40.89Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
91% recommend buying · 11 analysts
📊 JPI status : Waystar Holding Corp has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 WAY price target & analyst consensusprice $25.25

The price target · all analysts combined (11 targets)
Highest target · 2 firms of 11$38+50.5%
Median target · of 11 targets$33+30.7%
Lowest target · 1 firm of 11$27+6.9%
Current price$25.25
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 11100% $27 ↔ $38
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS58% of its targets hit on this sector (74 calls tested). It aims for $33 (+31 %), call made on July 31, 2026, maturing on July 31, 2027 (28 d ago).

The 1 reliable analyst $33+31 %
The 10 other firms $33+31 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $33 median. “The 10 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy1091%
Hold19%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Waystar Holding Corp? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on WAY

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Deutsche Bank  100% +61.8% 2
JP Morgan  100% +56.7% 2
Raymond James  100% +49.8% 2
RBC Capital  100% +48.9% 3
Evercore ISI Group  100% +43.3% 4
B of A Securities  67% +35.3% 3
Goldman Sachs  50% +8.8% 4
Canaccord Genuity  40% -2.0% 5
Barclays  25% -2.0% 4
Truist Securities  0% -40.9% 3

📊 What $1,000 invested in Waystar Holding Corp would be worth › open the full page

In short — $1,000 invested in Waystar Holding Corp 10 years ago would be worth $1,072 today, i.e. +4%/yr on average. Best year: 2025 (-15%), worst: 2025 (-15%). Price performance, excluding dividends.

If I'd invested $1,000 in Waystar Holding Corp

InvestmentWorth todayGain
1 years ago$600-40%
→ See Waystar Holding Corp's full return history + gain calculator

Return by year (Waystar Holding Corp)

YearReturn$1,000 invested at year start
2026 (YTD)-29%$707 (-29%)
2025-15%$600 (-40%)
→ See Waystar Holding Corp's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Waystar Holding Corp

Loading news…

📋 All analyst calls on WAY

▲ Buy · 🎯$33
Price at call : $24.78 — upside +33%
Today : $25.25 — upside +31%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 13, 27
Barclays 
Aug 7, 26
▲ Overweight · 🎯$27
Price at call : $24.7 — upside +9%
Today : $25.25 — upside +7%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 7, 27
UBS 
Jul 30, 26
▲ Buy · 🎯$33
Price at call : $21.11 — upside +56%
Today : $25.25 — upside +31%
🎯 on WAY : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Jul 30, 27
Wells Fargo 
Jul 30, 26
▲ Overweight · 🎯$33
Price at call : $21.11 — upside +56%
Today : $25.25 — upside +31%
🎯 on WAY : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jul 30, 27
Needham 
Jul 30, 26
▲ Buy · 🎯$33
Price at call : $20.94 — upside +58%
Today : $25.25 — upside +31%
🎯 on WAY : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jul 30, 27
Keybanc 
Jul 2, 26
▲ Overweight · 🎯$30
Price at call : $23.46 — upside +28%
Today : $25.25 — upside +19%
🎯 on WAY : no call matured yet · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jul 2, 27
Barclays 
May 20, 26
▲ Overweight · 🎯$25
Price at call : $18.83 — upside +33%
Today : $25.25 — upside -1%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 20, 27
Citigroup 
May 5, 26
▲ Buy · 🎯$30
Price at call : $19.9 — upside +51%
Today : $25.25 — upside +19%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : May 5, 27
See the other 43 calls, newest to oldest
JP Morgan 
May 1, 26
▲ Overweight · 🎯$38
Price at call : $20.95 — upside +81%
Today : $25.25 — upside +50%
🎯 on WAY : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : May 1, 27
UBS 
Apr 30, 26
▲ Buy · 🎯$37
Price at call : $20.95 — upside +77%
Today : $25.25 — upside +47%
🎯 on WAY : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Apr 30, 27
Needham 
Apr 30, 26
▲ Buy · 🎯$33
Price at call : $21.38 — upside +54%
Today : $25.25 — upside +31%
🎯 on WAY : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Apr 30, 27
▲ Buy · 🎯$38
Price at call : $21.5 — upside +77%
Today : $25.25 — upside +50%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Apr 10, 27
Morgan Stanley 
Mar 30, 26
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $24.11 — gap to target +16%
Today : $25.25 — gap to target +11%
🎯 on WAY : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 30, 27
Deutsche Bank 
Mar 12, 26
▲ Buy · 🎯$37
Price at call : $24.16 — upside +53%
Today : $25.25 — upside +47%
🎯 on WAY : no call matured yet · 📊 on Health : 32.7% · -7.6% (55 calls)
in progress (365j)
matures : Mar 12, 27
Wells Fargo 
Feb 19, 26
▲ Overweight · 🎯$36
Price at call : $25.07 — upside +44%
Today : $25.25 — upside +43%
🎯 on WAY : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 19, 27
▲ Buy · 🎯$30
Price at call : $25.79 — upside +16%
Today : $25.25 — upside +19%
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 18, 27
Citigroup 
Feb 18, 26
▲ Buy · 🎯$35
Price at call : $25.79 — upside +36%
Today : $25.25 — upside +39%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Feb 18, 27
BMO Capital 
Feb 18, 26
▲ Outperform · 🎯$30
Price at call : $25.79 — upside +16%
Today : $25.25 — upside +19%
🎯 on WAY : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Feb 18, 27
Goldman Sachs 
Feb 18, 26
▲ Buy · 🎯$38
Price at call : $25.79 — upside +47%
Today : $25.25 — upside +50%
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Feb 18, 27
Barclays 
Feb 18, 26
▲ Overweight · 🎯$36
Price at call : $25.79 — upside +40%
Today : $25.25 — upside +43%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Feb 18, 27
▲ Buy · 🎯$38
Price at call : $25.79 — upside +47%
Today : $25.25 — upside +50%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Feb 18, 27
▲ Outperform · 🎯$27
Price at call : $25.41 — upside +6%
Today : $25.25 — upside +7%
🎯 on WAY : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Feb 18, 27
▲ Buy · 🎯$33
Price at call : $25.41 — upside +30%
Today : $25.25 — upside +31%
🎯 on WAY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 18, 27
Needham 
Feb 17, 26
▲ Buy · 🎯$33
Price at call : $25.41 — upside +30%
Today : $25.25 — upside +31%
🎯 on WAY : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Feb 17, 27
Citigroup 
Jan 9, 26
▲ Buy · 🎯$46
Price at call : $31.59 — upside +46%
Today : $25.25 — upside +82%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Jan 9, 27
Wells Fargo 
Jan 9, 26
▲ Overweight · 🎯$41
Price at call : $34.5 — upside +19%
Today : $25.25 — upside +62%
🎯 on WAY : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 9, 27
UBS 
Dec 15, 25
▲ Buy · 🎯$41
Price at call : $32.9 — upside +25%
Today : $25.25 — upside +62%
🎯 on WAY : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Dec 15, 26
Barclays 
Dec 9, 25
▲ Overweight · 🎯$42
Price at call : $30.4 — upside +38%
Today : $25.25 — upside +66%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Dec 9, 26
■ Hold neutral · not a buy · 🎯$40
Price at call : $35.74 — gap to target +12%
Today : $25.25 — gap to target +58%
🎯 on WAY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 21, 26
BMO Capital 
Nov 13, 25
▲ Outperform · 🎯$47
Price at call : $35.75 — upside +31%
Today : $25.25 — upside +86%
🎯 on WAY : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Nov 13, 26
Needham 
Nov 11, 25
▲ Buy · 🎯$46
Price at call : $36.03 — upside +28%
Today : $25.25 — upside +82%
🎯 on WAY : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Nov 11, 26
Citigroup 
Oct 31, 25
▲ Buy · 🎯$49
Price at call : $37.03 — upside +32%
Today : $25.25 — upside +94%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 31, 26
▲ Buy · 🎯$54
Price at call : $35.85 — upside +51%
Today : $25.25 — upside +114%
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Oct 30, 26
Mizuho 
Oct 30, 25
▲ Outperform · 🎯$50
Price at call : $37.06 — upside +35%
Today : $25.25 — upside +98%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Oct 30, 26
JMP Securities
Sep 18, 25
▲ Market Outperform · 🎯$48
Price at call : $38.58 — upside +24%
Today : $25.25 — upside +90%
🎯 on WAY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 18, 26
Baird 
Sep 5, 25
▲ Outperform · 🎯$44
Price at call : $37.27 — upside +18%
Today : $25.25 — upside +74%
🎯 on WAY : no call matured yet · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Sep 5, 26
▲ Buy · 🎯$51
Price at call : $36.7 — upside +39%
Today : $25.25 — upside +102%
Expected +39% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-39.8%
stock -40% · XLV +21%
matured Jul 17, 26
Mizuho 
Jun 30, 25
▲ Outperform · 🎯$48
Price at call : $39.4 — upside +22%
Today : $25.25 — upside +90%
Expected +22% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 26.4% · -9.4% (87 calls)
-45.6%
stock -46% · XLV +17%
matured Jun 30, 26
Citigroup 
Jun 25, 25
▲ Buy · 🎯$45
Price at call : $39.27 — upside +15%
Today : $25.25 — upside +78%
Expected +15% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
-49.3%
stock -49% · XLV +19%
matured Jun 25, 26
▲ Buy · 🎯$50
Price at call : $40.01 — upside +25%
Today : $25.25 — upside +98%
Expected +25% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-50.3%
stock -50% · XLV +8%
matured May 8, 26
▲ Buy · 🎯$47
Price at call : $40.68 — upside +16%
Today : $25.25 — upside +86%
Expected +16% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-48.7%
stock -49% · XLV +4%
matured May 1, 26
Barclays 
Apr 14, 25
▲ Overweight · 🎯$45
Price at call : $36.93 — upside +22%
Today : $25.25 — upside +78%
Expected +22% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-33.2%
stock -33% · XLV +7%
matured Apr 14, 26
▲ Buy · 🎯$45
Price at call : $36.47 — upside +23%
Today : $25.25 — upside +78%
Expected +23% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-32.5%
stock -33% · XLV +4%
matured Mar 14, 26
▲ Buy · 🎯$50
Price at call : $42.07 — upside +19%
Today : $25.25 — upside +98%
Expected +19% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-40.0%
stock -40% · XLV +7%
matured Feb 24, 26
Goldman Sachs 
Feb 19, 25
▲ Buy · 🎯$52
Price at call : $41 — upside +27%
Today : $25.25 — upside +106%
Expected +27% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 51% · +5.1% (102 calls)
-38.9%
stock -39% · XLV +7%
matured Feb 19, 26
Barclays 
Feb 19, 25
▲ Overweight · 🎯$50
Price at call : $43.86 — upside +14%
Today : $25.25 — upside +98%
Expected +14% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-41.2%
stock -41% · XLV +7%
matured Feb 19, 26
Jefferies 
Feb 11, 25
▲ Buy · 🎯$51
Price at call : $42.48 — upside +20%
Today : $25.25 — upside +102%
Expected +20% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
-44.1%
stock -44% · XLV +7%
matured Feb 11, 26
Goldman Sachs 
Jan 14, 25
▲ Buy · 🎯$44
Price at call : $37.36 — upside +18%
Today : $25.25 — upside +74%
Expected +18% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 51% · +5.1% (102 calls)
-20.1%
stock -20% · XLV +13%
matured Jan 14, 26
▲ Buy · 🎯$43
Price at call : $37.5 — upside +15%
Today : $25.25 — upside +70%
Expected +15% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
-10.2%
stock -10% · XLV +14%
matured Jan 6, 26
Barclays 
Jan 6, 25
▲ Overweight · 🎯$42
Price at call : $37.5 — upside +12%
Today : $25.25 — upside +66%
Expected +12% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-13.3%
stock -13% · XLV +14%
matured Jan 6, 26
William Blair 
Jul 2, 24
▲ Outperform
Actual +83% · Reason (≥ +15%) : ✓ Yes
🎯 on WAY : 100% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
+83.0%
stock +83% · XLV -5%
matured Jul 2, 25

Frequently asked questions

Should I buy Waystar Holding Corp stock?

This isn't buy advice. For Waystar Holding Corp, the analyst consensus is "Buy", with an average price target of $33.00 (+31% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Waystar Holding Corp). We show the numbers — you decide.

Is it too late to buy Waystar Holding Corp? How high can it go?

The most bullish analyst target on Waystar Holding Corp is $38.00 (+50% above today's price); the average is $33.00. That's the upside they see. Check how reliable those analysts have actually been on Waystar Holding Corp on our site before trusting it.

Is Waystar Holding Corp still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Waystar Holding Corp, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.

Will Waystar Holding Corp stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will WAY stock recover (go back up)?

Should you invest in Waystar Holding Corp? The case for and against

The arguments for and against, one by one, from the numbers: why invest in WAY (and why hesitate).

What has Waystar Holding Corp's past performance been?

Historical returns and a "how much if I had invested" calculator: WAY performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)